weight loss expectations with tirzepatide Is a Game-Changer in Medical Treatment? Tirzepatide Weight Loss: Individual Outcomes

SURMOUNT-5: The First Direct Head-to-Head Trial For years, comparing tirzepatide weight loss results to semaglutide weight loss results required inferring from separate trials run in different patient groups

20% In a typical year, Compounded Tirzepatide users can experience a weight loss of 15-20%* Select your current weight: 270 lbs Weight you could lose (lbs): 58 lbs *In clinical trials lasting 68 and 72 weeks that investigated the effects of Wegovy (2.4 mg) and Zepbound (15 mg) on patients without diabetes who either had a BMI 30, or a BMI 27 with an accompanying weight-related condition, participants experienced an average weight loss of 15% and 20% respectively, when these medications were combined with modifications in diet and exercise

Approved by the FDA in late 2023, it offers a new option for people struggling with obesity

Tirzepatide is a prescription medication that acts on both GLP-1 and GIP receptors involved in appetite and metabolic regulation